Universitätsklinikum Schleswig-Holstein (UKSH)

Hospital


Location: Lübeck / Kiel, Germany (DE) DE

ISNI: 0000000406462097

ROR: https://ror.org/01tvm6f46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Treatment differences in IDH–wildtype glioma – the impact of surgery and adjuvant therapy (2026) Keric N, Krenzlin H, Lange F, Dauth A, Freyschlag CF, Schnellg O, Misch M, et al. Journal article Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland (2026) Simon L, Vucinic V, Rejeski K, Schubert ML, Aydilek E, Wagner-Drouet EM, Penack O, et al. Journal article Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy (2026) Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, et al. Journal article Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis (2026) Geidel G, Bänsch S, Adam L, Fekade N, Rünger A, Zell T, Smit DJ, et al. Journal article Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors Arzneimittelinteraktionen als Herausforderung bei der Monotherapie des fortgeschrittenen oder metastasierten klarzelligen Nierenzellkarzinoms mit VEGFR-assoziierten Tyrosinkinase-Inhibitoren (2026) Reinbold H, Goebell P, Merseburger AS Journal article, Review article Klinische Charakteristika neu diagnostizierter Patienten mit Primär Biliärer Cholangitis weisen auf die Notwendigkeit einer frühzeitigeren Diagnose und adäquaten UDCA Behandlung hin Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy (2025) Stein K, Hofmann WP, Franke A, Petroff D, Müller T, Bantel H, Günther R, et al. Journal article Digital health applications Digitale Gesundheitsanwendungen (2025) Leipe J, Hueber AJ Journal article Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany (2025) Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, et al. Journal article Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025) Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al. Journal article Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses (2025) Holtrop T, Brandsma AM, Feitsma LJ, Krohn S, Moerer P, van den Haak F, Versnel A, et al. Journal article